Bharat Biotech’s Rotavirus vaccine gets WHO Prequalification : The Tribune India

Join Whatsapp Channel

Bharat Biotech’s Rotavirus vaccine gets WHO Prequalification

It is the only rotavirus vaccine in the world to be delivered in a 0.5 ml dose volume; rotavirus is the leading cause of severe diarrhoea among children less than five years of age around the world

Bharat Biotech’s Rotavirus vaccine gets WHO Prequalification

Photo for representation. — iStock



Tribune News Service

New Delhi, August 2

Bharat Biotech on Monday announced that the World Health Organisation (WHO) has awarded prequalification to its rotavirus vaccine, ROTAVAC 5D, a

unique rotavirus vaccine formulation that can be administered without a buffer.

Its low dose volume (0.5 mL) facilitates easy vaccine logistics, cold chain management and low biomedical waste disposal post-vaccination.

It is used for the prevention of rotavirus infection, which is prevalent in infants and young children.

WHO Prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO (Pan American Health Association).

The WHO prequalification of ROTAVAC 5D will fast-track global access to this life saving vaccine.

Suchitra Ella, Joint Managing Director, Bharat Biotech, said, “ROTAVAC and its new variant ROTAVAC 5D are projects conceived, innovated, and executed in India; in collaboration with Indian and Global partners. This is the culmination of a 30 year effort to develop a novel rotavirus vaccine, resulting in a major advancement in Rotavirus disease prevention and reasserts India’s leadership in developing and introducing rotavirus vaccines for the world.”

Today’s announcement is an important step to further strengthen and fulfil Bharat Biotech’s vision to address neglected diseases, she said.

Bharat Biotech developed the first generation, rotavirus vaccine, ROTAVAC under a Public-Private Partnership with the Department of Biotechnology, Government of India, and 16 other international partners, making it the largest ever social innovation project for public health.

In the developing world, ROTAVAC has been instrumental in addressing deaths due to rotavirus infection.

Bharat Biotech has so far supplied more than 250 million doses of ROTAVAC.

Rotavirus is the leading cause of severe diarrhoea among children less than five years of age around the world, resulting in more than 200,000 deaths and 2 million hospitalisations worldwide. Vaccinations are an important part of global public health efforts to meet the Sustainable Developmental Goals of UNDP.


Top News

India summons Canadian diplomat over raising of pro-Khalistan slogans at event attended by PM Justin Trudeau

India summons Canadian deputy envoy over pro-Khalistan slogans at event attended by PM Justin Trudeau

Ministry of External Affairs describes the raising of slogan...

Uttarakhand suspends licences of 14 products made by Ramdev's pharmaceutical companies

Uttarakhand suspends licences of 14 products made by Ramdev's pharmaceutical companies

The list of 14 products whose licences were suspended includ...

Supreme Court recalls order for termination of 30-week pregnancy of 14-year-old rape survivor

Supreme Court recalls order for termination of 30-week pregnancy of 14-year-old rape survivor

Bench led by CJI Chandrachud withdraws its April 22 order af...

Telangana CM Revanth Reddy summoned by Delhi Police to join probe in Amit Shah’s doctored video case

Amit Shah's 'doctored' video: Delhi Police summon Telangana CM Revanth Reddy, one arrested in Assam

Revanth Reddy says he will not be afraid about notice over p...

Supreme Court stays CBI probe into West Bengal government officials' role in teacher recruitment scam

Supreme Court stays CBI probe into West Bengal Government officials' role in teacher recruitment scam

Top court, however, refuses to stay High Court order cancell...


Cities

View All